ALICIA PILAR HERRERO AMBROSIO-rekin lankidetzan egindako argitalpenak (7)

2023

  1. Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathies

    Expert Review of Hematology, Vol. 16, Núm. 3, pp. 213-226

2021

  1. Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 5, pp. 268-272

2016

  1. Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25 years and its potential association with bleeding episodes

    Thrombosis Research, Vol. 143, pp. 22-27

2014

  1. Adequacy of clotting factor in haemophilic patients underwent surgery based on analytical parameters and plasmatic clearance

    Atencion Farmaceutica, Vol. 16, Núm. 2, pp. 110-116

2013

  1. Lipid profile disorder in HIV infected patients treated with lopinavir/ritonavir and its relation with adherence To treatment

    Atencion Farmaceutica, Vol. 15, Núm. 3, pp. 171-177

  2. Trastuzumab induced cardiotoxicity in patients with HER2+ breast cancer

    Atencion Farmaceutica, Vol. 15, Núm. 4, pp. 261-267

2011

  1. Trastorno de la agregación plaquetaria debido a amitriptilina

    Farmacia Hospitalaria